New shots aim to shield kids from deadly malaria
NCT ID NCT07183371
Summary
This study is testing two new malaria vaccine combinations in young children in Burkina Faso, where malaria is common. It will involve 360 healthy children aged 5 to 36 months to see if the vaccines are safe and how well they prevent malaria over six months. The goal is to find a better way to protect young children from this serious disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN)
Nanoro, Burkina Faso
Conditions
Explore the condition pages connected to this study.